Clinical Case Reviews and Poster Sessions in Multiple Sclerosis Spasticity: Main Outcomes and Highlights

Publisher： Karger

E-ISSN： 1421-9913|72|1|15-19

ISSN： 0014-3022

Source： European Neurology, Vol.72, Iss.1, 2014-09, pp. : 15-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advances in the Management of Multiple Sclerosis Spasticity: Recent Clinical Trials

By  

European Neurology, Vol. 72, Iss. 1, 2014-09 ,pp. : 9-11

Karger

Access to resources Recommend Favorite

Advances in the Management of Multiple Sclerosis Spasticity: Multiple Sclerosis Spasticity Nervous Pathways

By  

European Neurology, Vol. 72, Iss. 1, 2014-09 ,pp. : 6-8

Karger

Access to resources Recommend Favorite

Nabiximols (THC/CBD Oromucosal Spray, Sativex®) in Clinical Practice - Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity

By  

European Neurology, Vol. 71, Iss. 5-6, 2014-02 ,pp. : 271-279

Karger

Access to resources Recommend Favorite

Effectiveness and Tolerability of THC/CBD Oromucosal Spray for Multiple Sclerosis Spasticity in Italy: First Data from a Large Observational Study

By  

European Neurology, Vol. 74, Iss. 3-4, 2015-11 ,pp. : 178-185

Karger

Access to resources Recommend Favorite

Tetrahydrocannabinol:Cannabidiol Oromucosal Spray for Multiple Sclerosis-Related Resistant Spasticity in Daily Practice

By  

European Neurology, Vol. 76, Iss. 5-6, 2016-10 ,pp. : 216-226

Karger

Access to resources Recommend Favorite